Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

USFDA completes GMP inspection at Dr. Reddy's Laboratories’ R&D centre

Date: 20-09-2024

United States Food & Drug Administration (USFDA) has completed a routine Good Manufacturing Practice (GMP) inspection at Dr. Reddy's Laboratories’ R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad.

The inspection was conducted from September 16, 2024 to September 20, 2024. The inspection closed with zero observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.